Answers are grounded in this paper and cite their sources.
Biliary tract cancers (BTC) represent an aggressive disease with a dismal prognosis. Gemcitabine in combination with cisplatin is the standard first-line palliative treatment for advanced BTC. There is no established treatment following progression on gemcitabine-cisplatin. In this article, we present two cases for individuals with advanced BTC who were treated with pembrolizumab and the tumors have completely resolved.
No takes yet. Share an insight, caveat, or question.
Alshari et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: